Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-10 Ciechanover Isaac E. Chief Executive Officer Sale −4,500 $19.64 $88K 384,278
2018-01-10 Ciechanover Isaac E. Chief Executive Officer Sale −4,100 $20.38 $84K 380,178
2017-12-29 MCGRATH JOHN EVP & Chief Financial Officer Sale −32,000 $20.00 $640K 96,654
2017-12-29 Ciechanover Isaac E. Chief Executive Officer Sale −14,400 $18.24 $263K 394,378
2017-12-29 Ciechanover Isaac E. Chief Executive Officer Sale −2,900 $19.04 $55K 391,478
2017-12-29 Ciechanover Isaac E. Chief Executive Officer Sale −2,700 $20.28 $55K 388,778
2017-12-28 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $15.15 $33K 408,778
2017-12-13 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $14.73 $32K 410,978
2017-12-12 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $14.56 $32K 413,178
2017-11-30 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $14.40 $32K 415,378
2017-11-29 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $14.09 $31K 417,578
2017-11-17 Soffer Gad EVP & Chief Strategy Officer Sale −7,000 $15.00 $105K 256,236
2017-11-16 Clark Mitchall G. EVP & Chief R & QA Officer Sale −3,290 $14.20 $47K 163,052
2017-11-16 Gallagher Carol Giltner Director Sale −1,184 $14.20 $17K 109,738
2017-11-15 Soffer Gad EVP & Chief Strategy Officer Option exercise +4,146 263,236
2017-11-15 Soffer Gad EVP & Chief Strategy Officer Option exercise · Restricted Stock Units −4,146 2,764
2017-11-15 Haqq Christopher EVP, R&D & Chief Scientific Of Option exercise +829 344,134
2017-11-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −1,604 $13.36 $21K 342,530
2017-11-15 Haqq Christopher EVP, R&D & Chief Scientific Of Option exercise · Restricted Stock Units −829 553
2017-11-15 Ciechanover Isaac E. Chief Executive Officer Option exercise +5,908 743,675

Page 39 of 44 · 867 trades